Free Trial

Grail Q2 2024 Earnings Report

Grail logo
$40.73 -7.03 (-14.72%)
As of 02/21/2025 04:00 PM Eastern

Grail EPS Results

Actual EPS
-$5.30
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Grail Revenue Results

Actual Revenue
$31.97 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Grail Announcement Details

Quarter
Q2 2024
Time
N/A

Conference Call Resources

Grail Earnings Headlines

Why Grail (GRAL) Is Falling Today
Ex-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000”
Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. Should you sit on the sideline while this is happening?
GRAIL, Inc. (GRAL) Q4 2024 Earnings Call Transcript
Grail Inc options imply 13.5% move in share price post-earnings
See More Grail Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Grail? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Grail and other key companies, straight to your email.

About Grail

Grail (NASDAQ:GRAL) is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.

View Grail Profile

More Earnings Resources from MarketBeat